Back to Search
Start Over
A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imaging.
- Source :
- British Journal of Cancer; 5/22/2006, Vol. 94 Issue 10, p1420-1427, 8p, 1 Black and White Photograph, 2 Charts, 5 Graphs
- Publication Year :
- 2006
-
Abstract
- Dynamic contrast-enhanced MR imaging (DCE-MRI) may act as a biomarker for successful cancer therapy. Simple, reproducible techniques may widen this application. This paper demonstrates a single slice imaging technique. The image acquisition is performed in less than 500 ms making it relatively insensitive to respiratory motion. Data from phantom studies and a reproducibility study in solid human tumours are presented. The reproducibility study showed a coefficient of variation (CoV) of 19.1% for K(trans) and 15.8% for the initial area under the contrast enhancement curve (IAUC). This was improved to 16 and 13.9% if tumours of diameter less than 3 cm were excluded. The individual repeatability (the range within which individual measurements are expected to fall) was 30.6% for K(trans) and 26.5% for IAUC for tumours greater than 3 cm diameter. This approach to DCE-MRI image acquisition can be performed with standard clinical scanners, and data analysis is straightforward. For treatment trials with 10 patients in a cohort, the CoV implies that the method would be sensitive to a treatment effect of greater than 18%. The individual repeatability is well inside the 40% change shown to be important in clinical studies using this DCE-MRI technique. [ABSTRACT FROM AUTHOR]
- Subjects :
- CANCER treatment
TUMORS
MAGNETIC resonance imaging
TUMOR markers
BIOMARKERS
Subjects
Details
- Language :
- English
- ISSN :
- 00070920
- Volume :
- 94
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- British Journal of Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 20927884
- Full Text :
- https://doi.org/10.1038/sj.bjc.6603140